BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33254286)

  • 21. The quality of subgroup analyses in chronic pain randomized controlled trials: a methodological review.
    AminiLari M; Ashoorian V; Caldwell A; Rahman Y; Nieuwlaat R; Busse JW; Mbuagbaw L
    Korean J Pain; 2021 Apr; 34(2):139-155. PubMed ID: 33785666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prone position for acute respiratory failure in adults.
    Bloomfield R; Noble DW; Sudlow A
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD008095. PubMed ID: 26561745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
    Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
    Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: systematic review.
    Sun X; Briel M; Busse JW; You JJ; Akl EA; Mejza F; Bala MM; Bassler D; Mertz D; Diaz-Granados N; Vandvik PO; Malaga G; Srinathan SK; Dahm P; Johnston BC; Alonso-Coello P; Hassouneh B; Truong J; Dattani ND; Walter SD; Heels-Ansdell D; Bhatnagar N; Altman DG; Guyatt GH
    BMJ; 2011 Mar; 342():d1569. PubMed ID: 21444636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials.
    Hernandez AV; Usmani A; Rajamanickam A; Moheet A
    Am J Cardiovasc Drugs; 2011; 11(2):115-28. PubMed ID: 21294599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incentives for increasing prenatal care use by women in order to improve maternal and neonatal outcomes.
    Till SR; Everetts D; Haas DM
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009916. PubMed ID: 26671418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subgroup analysis in randomized controlled trials appeared to be dependent on whether relative or absolute effect measures were used.
    Venekamp RP; Rovers MM; Hoes AW; Knol MJ
    J Clin Epidemiol; 2014 Apr; 67(4):410-5. PubMed ID: 24508145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal Trends and Factors Associated With the Inclusion of Patient-Reported Outcomes in Heart Failure Randomized Controlled Trials: A Systematic Review.
    Eliya Y; Averbuch T; Le N; Xie F; Thabane L; Mamas MA; Van Spall HGC
    J Am Heart Assoc; 2021 Nov; 10(21):e022353. PubMed ID: 34689608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for prostate cancer.
    Ilic D; Neuberger MM; Djulbegovic M; Dahm P
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of selective reporting bias in hematology journals: A systematic review.
    Wayant C; Scheckel C; Hicks C; Nissen T; Leduc L; Som M; Vassar M
    PLoS One; 2017; 12(6):e0178379. PubMed ID: 28570573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inconsistent Outcome Reporting in Heart Failure Randomized Controlled Trials.
    Siddiqi TJ; Shahid I; Arshad MS; Greene SJ; Pandey A; Vaduganathan M; VAN Spall HGC; Mentz RJ; Fonarow GC; Khan MS
    J Card Fail; 2023 Apr; 29(4):425-433. PubMed ID: 36513272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of telemedicine systems for adults with heart failure: a meta-analysis of randomized controlled trials.
    Zhu Y; Gu X; Xu C
    Heart Fail Rev; 2020 Mar; 25(2):231-243. PubMed ID: 31197564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses.
    Schandelmaier S; Briel M; Varadhan R; Schmid CH; Devasenapathy N; Hayward RA; Gagnier J; Borenstein M; van der Heijden GJMG; Dahabreh IJ; Sun X; Sauerbrei W; Walsh M; Ioannidis JPA; Thabane L; Guyatt GH
    CMAJ; 2020 Aug; 192(32):E901-E906. PubMed ID: 32778601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Airway clearance devices for cystic fibrosis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(26):1-50. PubMed ID: 23074531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community-based care for the specialized management of heart failure: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(17):1-42. PubMed ID: 23074521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Justification and reporting of subgroup analyses were lacking or inadequate in randomized controlled trials.
    Fan J; Song F; Bachmann MO
    J Clin Epidemiol; 2019 Apr; 108():17-25. PubMed ID: 30557676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data.
    Pufulete M; Maishman R; Dabner L; Higgins JPT; Rogers CA; Dayer M; MacLeod J; Purdy S; Hollingworth W; Schou M; Anguita-Sanchez M; Karlström P; Shochat MK; McDonagh T; Nightingale AK; Reeves BC
    Syst Rev; 2018 Jul; 7(1):112. PubMed ID: 30064502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subgroup analyses in randomized controlled trials frequently categorized continuous subgroup information.
    Williamson SF; Grayling MJ; Mander AP; Noor NM; Savage JS; Yap C; Wason JMS
    J Clin Epidemiol; 2022 Oct; 150():72-79. PubMed ID: 35788399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is There Truly "No Significant Difference"? Underpowered Randomized Controlled Trials in the Orthopaedic Literature.
    Abdullah L; Davis DE; Fabricant PD; Baldwin K; Namdari S
    J Bone Joint Surg Am; 2015 Dec; 97(24):2068-73. PubMed ID: 26677241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.
    Pufulete M; Maishman R; Dabner L; Mohiuddin S; Hollingworth W; Rogers CA; Higgins J; Dayer M; Macleod J; Purdy S; McDonagh T; Nightingale A; Williams R; Reeves BC
    Health Technol Assess; 2017 Aug; 21(40):1-150. PubMed ID: 28774374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.